Search clinical trials for: Serotonin Receptor Agonists

Total 24062 results

Jinling Hospital, China

Completed

Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery

Postoperative Ileus

China
University of Calgary
Janssen Inc.

Completed

Prucalopride Versus Placebo in Gastroparesis

Diabetes Mellitus | Gastroparesis

Canada
University of British Columbia

Unknown

Prucalopride Prior to Small Bowel Capsule Endoscopy

Intestinal Diseases | Inflammatory Bowel Diseases | Celiac Disease | Crohn Disease | Gastrointestinal Hemorrhage

Canada
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States
Pfizer

Completed

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Migraine

United States
Mayo Clinic
ARYx Therapeutics

Completed

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Movetis

Completed

Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility

Constipation
University of Oxford

Completed

Prucalopride and Cognition in Recovered Depression (PROGRESS)

Depression in Remission

United Kingdom
Zogenix, Inc.

Completed

A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs

Healthy
Danish Headache Center

Completed

PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea

Rosacea

Denmark
Dr. Reddy's Laboratories Limited

Completed

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

Rapidly Escalating Migraine

United States
Movetis
FOCUS GmbH

Completed

M0001 Effects on Oral Contraceptive Plasma Levels

Healthy Volunteers

Germany
AstraZeneca

Completed

Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

Migraine
AstraZeneca

Completed

Efficacy and Tolerability of Zolmitriptan Nasal Spray

Migraine
Movetis

Completed

Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation

Constipation
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
University of Texas Southwestern Medical Center

Completed

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

Alcoholism | Bipolar Disorder | Alcohol Abuse

United States
Shanghai Mental Health Center

Withdrawn

Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Once-monthly in Patients With Schizophrenia

Schizophrenia

United States
CMG Pharmaceutical Co. Ltd

Completed

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Schizophrenia
US Department of Veterans Affairs

Withdrawn

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Methamphetamine Dependence
Wei Hao

Terminated

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

China
Otsuka Pharmaceutical Development & Commercialization...
Covance

Completed

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia (ASPIRE)

Schizophrenia

Spain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
Duke University
Bristol-Myers Squibb

Completed

Metabolic Signatures and Biomarkers in Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Schizophrenia

United States
North Suffolk Mental Health Association
Eli Lilly and Company

Completed

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Psychotic Disorders | Schizophrenia
Taichung Veterans General Hospital

Unknown

Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine (HeartAriQue)

Schizophrenia | Bipolar

Taiwan
Duke University
The Emmes Company, LLC

Completed

Long-term Antipsychotic Pediatric Safety Trial (LAPS)

Weight, Body

United States
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I

Japan
Peking University

Completed

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Acute Schizophrenia Episode

China
New York State Psychiatric Institute
Bristol-Myers Squibb; National Institute of Mental Health (NIMH); Otsuka Pharmaceutical...

Terminated

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants (TREAT)

Attention Deficit Hyperactivity Disorder

United States
Indiana University
Bristol-Myers Squibb; National Institute of Mental Health (NIMH)

Completed

Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

Pervasive Developmental Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Schizophrenia | Major Depressive Disorder | Bipolar I Disorder

United States
Massachusetts General Hospital
Bristol-Myers Squibb

Completed

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy

Major Depressive Disorder

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression

Terminated

Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Fundación Marques de Valdecilla
Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación...

Completed

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis (PAFIP2)

Psychotic Disorders | Schizophrenia

Spain
Alkermes, Inc.

Completed

A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S; Otsuka America Pharmaceutical

Completed

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

United States, Croatia, Latvia
Reviva Pharmaceuticals

Completed

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder (REFRESH)

Schizoaffective Disorder | Acute Schizophrenia

United States, India, Malaysia, Moldova, Republic of, Philippines
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Paul Saenger

Unknown

A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence

Schizophrenia | Cocaine Dependence

United States
Massachusetts General Hospital

Terminated

Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents

Pediatric Bipolar Disorder

United States
Vanderbilt University Medical Center

Recruiting

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Autism Spectrum Disorder | Weight Gain | Medication Side Effect

United States
Northwell Health
National Institutes of Health (NIH)

Completed

Striatal Connectivity and Clinical Outcome in Psychosis

Psychotic Disorders

United States
Genuine Research Center, Egypt
P&C Labs, Egypt

Completed

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Healthy

Egypt

Search clinical trials for: Serotonin Receptor Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations